drugset / Trial / NCT05181085
Study of NST-6179 in Healthy Subjects
RandomizedSequentialTriple-blindTreatment
Summary
A double-blind, randomized, placebo controlled, single and multiple oral dose study to assess safety and tolerability of single and multiple doses of NST-6179 in healthy male and female subjects.
Timeline
- Start
- 2021-11-11
- Primary completion
- 2022-05-27
- Completion
- 2022-05-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Orziloben | Small molecule | — | Oral |